logo
ProjectGrant Award

Accelerating Commercialisation

The status, timeline and source of this project. A free account opens every field.

Source: GrantConnect

Biosensis has developed a novel, ultra–sensitive enzyme–linked immunosorbent assay (ELISA) for use by medical researchers in universities and industry. These novel kits will allow potential tools for detection and measurement of diseases previously not possible due to lack of sensitivity in tests. Accelerating Commercialisation support will be used to help Biosensis commercialise these state–of–t

Status
Prospective
Sector
Education, Hospital, Government
Location
Australia
Updated
19 Nov 2026
Source
GrantConnect

ConstructChat

Ask ConstructChat about Accelerating Commercialisation

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Accelerating Commercialisation” is an infrastructure initiative in the Education sector, located in Australia. Taiyo aggregates data on it from GrantConnect.

Participants

Sponsoring Agency

Status

Original status

grant award

Taiyo status

Prospective

Taiyo last update

2026-11-19

Contact

Not available for this record.

Description

Description

Biosensis has developed a novel, ultra–sensitive enzyme–linked immunosorbent assay (ELISA) for use by medical researchers in universities and industry. These novel kits will allow potential tools for detection and measurement of diseases previously not possible due to lack of sensitivity in tests. Accelerating Commercialisation support will be used to help Biosensis commercialise these state–of–the–art ELISA kits and achieve significant export sales, while assisting in the diagnosis and treatment of diseases that have poor or non–existent treatment options.

Original sector

Business Development

Budget

Location

Country

Australia

Source

Source

GrantConnect

URL

More Details

Record type

Project

Sector

Education, Hospital, Government

Article published date

2024-12-16

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project